Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT01434316
Show Display Options
Rank Status Study
1 Recruiting Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors
Conditions: Advanced Malignant Solid Neoplasm;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation
Interventions: Drug: Dinaciclib;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Veliparib

Study has passed its completion date and status has not been verified in more than two years.